1
|
Huang Y, Han Z, Shen T, Zheng Y, Yang Z, Fan J, Wang R, Yan F, Tao Z, Luo Y, Liu P. Neutrophil migration participates in the side effect of recombinant human tissue plasminogen activator. CNS Neurosci Ther 2024; 30:e14825. [PMID: 38954749 PMCID: PMC11218914 DOI: 10.1111/cns.14825] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2023] [Revised: 05/21/2024] [Accepted: 06/01/2024] [Indexed: 07/04/2024] Open
Abstract
AIMS Ischemic stroke remains a challenge in medical research because of the limited treatment options. Recombinant human tissue plasminogen activator (rtPA) is the primary treatment for recanalization. However, nearly 50% of the patients experience complications that result in ineffective reperfusion. The precise factors contributing to ineffective reperfusion remain unclear; however, recent studies have suggested that immune cells, notably neutrophils, may influence the outcome of rtPA thrombolysis via mechanisms such as the formation of neutrophil extracellular traps. This study aimed to explore the nonthrombolytic effects of rtPA on neutrophils and highlight their contribution to ineffective reperfusion. METHODS We evaluated the effects of rtPA treatment on middle cerebral artery occlusion in rats. We also assessed neutrophil infiltration and activation after rtPA treatment in vitro and in vivo in a small cohort of patients with massive cerebral ischemia (MCI). RESULTS rtPA increased neutrophil infiltration into the brain microvessels and worsened blood-brain barrier damage during ischemia. It also increased the neutrophil counts of the patients with MCI. CONCLUSION Neutrophils play a crucial role in promoting ischemic injury and blood-brain barrier disruption, making them potential therapeutic targets.
Collapse
Affiliation(s)
- Yuyou Huang
- Department of Neurology and Institute of Cerebrovascular Diseases ResearchXuanwu Hospital of Capital Medical UniversityBeijingChina
| | - Ziping Han
- Department of Neurology and Institute of Cerebrovascular Diseases ResearchXuanwu Hospital of Capital Medical UniversityBeijingChina
| | - Tong Shen
- Department of Neurology and Institute of Cerebrovascular Diseases ResearchXuanwu Hospital of Capital Medical UniversityBeijingChina
| | - Yangmin Zheng
- Department of Neurology and Institute of Cerebrovascular Diseases ResearchXuanwu Hospital of Capital Medical UniversityBeijingChina
| | - Zhenhong Yang
- Department of Neurology and Institute of Cerebrovascular Diseases ResearchXuanwu Hospital of Capital Medical UniversityBeijingChina
| | - Junfen Fan
- Department of Neurology and Institute of Cerebrovascular Diseases ResearchXuanwu Hospital of Capital Medical UniversityBeijingChina
| | - Rongliang Wang
- Department of Neurology and Institute of Cerebrovascular Diseases ResearchXuanwu Hospital of Capital Medical UniversityBeijingChina
| | - Feng Yan
- Department of Neurology and Institute of Cerebrovascular Diseases ResearchXuanwu Hospital of Capital Medical UniversityBeijingChina
| | - Zhen Tao
- Department of Neurology and Institute of Cerebrovascular Diseases ResearchXuanwu Hospital of Capital Medical UniversityBeijingChina
| | - Yumin Luo
- Department of Neurology and Institute of Cerebrovascular Diseases ResearchXuanwu Hospital of Capital Medical UniversityBeijingChina
- Beijing Institute for Brain Disorders, Capital Medical UniversityBeijingChina
| | - Ping Liu
- Department of Neurology and Institute of Cerebrovascular Diseases ResearchXuanwu Hospital of Capital Medical UniversityBeijingChina
| |
Collapse
|
2
|
Chmielecki A, Bortnik K, Galczynski S, Kopacz K, Padula G, Jerczynska H, Stawski R, Nowak D. Interleukin-4 during post-exercise recovery negatively correlates with the production of phagocyte-generated oxidants. Front Physiol 2023; 14:1186296. [PMID: 38192745 PMCID: PMC10773862 DOI: 10.3389/fphys.2023.1186296] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2023] [Accepted: 11/02/2023] [Indexed: 01/10/2024] Open
Abstract
Exhaustive run induced a biphasic oxidative response of circulating phagocytes in 16 amateur sportsmen. The first phase involved an increment just after exercise of enhanced whole blood chemiluminescence normalized per phagocyte count, whereas in the second phase a decrement from 1 h post-exercise and ongoing till 24 h. We tested whether plasma Interleukin IL-4, IL-8, IL-10 and Tumor Necrosis Factor α concentrations change in response to exhaustive run and whether there are associations between their levels and delta resting. Moreover, IL-8 and IL-10 significantly increased immediately post-exercise and after 1 h, but later normalized. Tumor necrosis factor α rose by 1.1-times only just after exercise. However, none of these cytokines showed any correlation with the investigated chemiluminescence. Exercise did not alter plasma concentrations of IL-4. However, pre-exercise IL-4 negatively correlated with measured luminescence just after exercise (ρ = -0.54, p < 0.05), and also tended to be negatively associated with decrements of the second phase at 1 h post-exercise ρ = -0.45, p = 0.08. It is suggested that plasma IL-4, by a negative association with blood phagocytes oxidants production, could be involved in the maintenance of proper balance between oxidants and anti-oxidants during strenuous exercise and post-exercise recovery.
Collapse
Affiliation(s)
| | | | - Szymon Galczynski
- Academic Laboratory of Movement and Human Physical Performance “DynamoLab”, Medical University of Lodz, Łódź, Poland
| | - Karolina Kopacz
- Academic Laboratory of Movement and Human Physical Performance “DynamoLab”, Medical University of Lodz, Łódź, Poland
| | - Gianluca Padula
- Academic Laboratory of Movement and Human Physical Performance “DynamoLab”, Medical University of Lodz, Łódź, Poland
| | - Hanna Jerczynska
- Central Scientific Laboratory, Medical University of Lodz, Łódź, Poland
| | - Robert Stawski
- Department of Clinical Physiology, Medical University of Lodz, Łódź, Poland
| | - Dariusz Nowak
- Department of Clinical Physiology, Medical University of Lodz, Łódź, Poland
| |
Collapse
|
3
|
Li L, Han Z, Wang R, Fan J, Zheng Y, Huang Y, Yang Z, Yan F, Liu P, Zhao H, Ma Q, Luo Y. Association of admission neutrophil serine proteinases levels with the outcomes of acute ischemic stroke: a prospective cohort study. J Neuroinflammation 2023; 20:70. [PMID: 36906528 PMCID: PMC10007819 DOI: 10.1186/s12974-023-02758-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2022] [Accepted: 03/07/2023] [Indexed: 03/13/2023] Open
Abstract
BACKGROUND Neutrophil serine proteinases (NSPs), released by activated neutrophils, are key proteins involved in the pathophysiologic processes of stroke. NSPs are also implicated in the process and response of thrombolysis. This study aimed to analyze three NSPs (neutrophil elastase, cathepsin G, and proteinase 3) in relation to acute ischemic stroke (AIS) outcomes and in relation to the outcomes of patients treated with intravenous recombinant tissue plasminogen activator (IV-rtPA). METHODS Among 736 patients prospectively recruited at the stroke center from 2018 to 2019, 342 patients diagnosed with confirmed AIS were included. Plasma neutrophil elastase (NE), cathepsin G (CTSG), and proteinase 3 (PR3) concentrations were measured on admission. The primary endpoint was unfavorable outcome defined as modified Rankin Scale score 3-6 at 3 months, and the secondary endpoints were symptomatic intracerebral hemorrhage (sICH) within 48 h, and mortality within 3 months. In the subgroup of patients who received IV-rtPA, post-thrombolysis early neurological improvement (ENI) (defined as National Institutes of Health Stroke Scale score = 0 or decrease of ≥ 4 within 24 h after thrombolysis) was also included as the secondary endpoint. Univariate and multivariate logistic regression analyses were performed to evaluate the association between NSPs levels and AIS outcomes. RESULTS Higher NE and PR3 plasma levels were associated with the 3-month mortality and 3-month unfavorable outcome. Higher NE plasma levels were also associated with the risk of sICH after AIS. After adjusting for potential confounders, plasma NE level > 229.56 ng/mL (odds ratio [OR] = 4.478 [2.344-8.554]) and PR3 > 388.77 ng/mL (OR = 2.805 [1.504-5.231]) independently predicted the 3-month unfavorable outcome. Regarding rtPA treatment, patients with NE plasma concentration > 177.22 ng/mL (OR = 8.931 [2.330-34.238]) or PR3 > 388.77 ng/mL (OR = 4.275 [1.045-17.491]) were over 4 times more likely to suffer unfavorable outcomes after rtPA treatment. The addition of NE and PR3 to clinical predictors of unfavorable functional outcome after AIS and the outcome after rtPA treatment improved discrimination as well as reclassification (integrated discrimination improvement = 8.2% and 18.1%, continuous net reclassification improvement = 100.0% and 91.8%, respectively). CONCLUSIONS Plasma NE and PR3 are novel and independent predictors of 3-month functional outcomes after AIS. Plasma NE and PR3 also possess predictive value to identify patients with unfavorable outcomes after rtPA treatment. NE is probably an important mediator of the effects of neutrophils on stroke outcomes, which worth further investigation.
Collapse
Affiliation(s)
- Lingzhi Li
- Institute of Cerebrovascular Diseases Research and Department of Neurology, Xuanwu Hospital of Capital Medical University, 45 Changchun Street, Beijing, 100053, China.,Beijing Key Laboratory of Translational Medicine for Cerebrovascular Diseases, Beijing, China
| | - Ziping Han
- Institute of Cerebrovascular Diseases Research and Department of Neurology, Xuanwu Hospital of Capital Medical University, 45 Changchun Street, Beijing, 100053, China.,Beijing Key Laboratory of Translational Medicine for Cerebrovascular Diseases, Beijing, China
| | - Rongliang Wang
- Institute of Cerebrovascular Diseases Research and Department of Neurology, Xuanwu Hospital of Capital Medical University, 45 Changchun Street, Beijing, 100053, China.,Beijing Key Laboratory of Translational Medicine for Cerebrovascular Diseases, Beijing, China
| | - Junfen Fan
- Institute of Cerebrovascular Diseases Research and Department of Neurology, Xuanwu Hospital of Capital Medical University, 45 Changchun Street, Beijing, 100053, China.,Beijing Key Laboratory of Translational Medicine for Cerebrovascular Diseases, Beijing, China
| | - Yangmin Zheng
- Institute of Cerebrovascular Diseases Research and Department of Neurology, Xuanwu Hospital of Capital Medical University, 45 Changchun Street, Beijing, 100053, China
| | - Yuyou Huang
- Institute of Cerebrovascular Diseases Research and Department of Neurology, Xuanwu Hospital of Capital Medical University, 45 Changchun Street, Beijing, 100053, China.,Beijing Key Laboratory of Translational Medicine for Cerebrovascular Diseases, Beijing, China
| | - Zhenhong Yang
- Institute of Cerebrovascular Diseases Research and Department of Neurology, Xuanwu Hospital of Capital Medical University, 45 Changchun Street, Beijing, 100053, China.,Beijing Key Laboratory of Translational Medicine for Cerebrovascular Diseases, Beijing, China
| | - Feng Yan
- Institute of Cerebrovascular Diseases Research and Department of Neurology, Xuanwu Hospital of Capital Medical University, 45 Changchun Street, Beijing, 100053, China.,Beijing Key Laboratory of Translational Medicine for Cerebrovascular Diseases, Beijing, China
| | - Ping Liu
- Institute of Cerebrovascular Diseases Research and Department of Neurology, Xuanwu Hospital of Capital Medical University, 45 Changchun Street, Beijing, 100053, China.,Beijing Key Laboratory of Translational Medicine for Cerebrovascular Diseases, Beijing, China
| | - Haiping Zhao
- Institute of Cerebrovascular Diseases Research and Department of Neurology, Xuanwu Hospital of Capital Medical University, 45 Changchun Street, Beijing, 100053, China.,Beijing Key Laboratory of Translational Medicine for Cerebrovascular Diseases, Beijing, China
| | - Qingfeng Ma
- Institute of Cerebrovascular Diseases Research and Department of Neurology, Xuanwu Hospital of Capital Medical University, 45 Changchun Street, Beijing, 100053, China
| | - Yumin Luo
- Institute of Cerebrovascular Diseases Research and Department of Neurology, Xuanwu Hospital of Capital Medical University, 45 Changchun Street, Beijing, 100053, China. .,Beijing Key Laboratory of Translational Medicine for Cerebrovascular Diseases, Beijing, China. .,Beijing Institute for Brain Disorders, Beijing, China.
| |
Collapse
|
4
|
Zhao Z, Pan Z, Zhang S, Ma G, Zhang W, Song J, Wang Y, Kong L, Du G. Neutrophil extracellular traps: A novel target for the treatment of stroke. Pharmacol Ther 2023; 241:108328. [PMID: 36481433 DOI: 10.1016/j.pharmthera.2022.108328] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2022] [Revised: 11/30/2022] [Accepted: 11/30/2022] [Indexed: 12/12/2022]
Abstract
Stroke is a threatening cerebrovascular disease caused by thrombus with high morbidity and mortality rates. Neutrophils are the first to be recruited in the brain after stroke, which aggravate brain injury through multiple mechanisms. Neutrophil extracellular traps (NETs), as a novel regulatory mechanism of neutrophils, can trap bacteria and secret antimicrobial molecules, thereby degrading pathogenic factors and killing bacteria. However, NETs also exacerbate certain non-infectious diseases by activating autoimmune or inflammatory responses. NETs have been found to play important roles in the pathological process of stroke in recent years. In this review, the mechanisms of NETs formation, the physiological roles of NETs, and the dynamic changes of NETs after stroke are summarized. NETs participate in stroke through various mechanisms. NETs promote the coagulation cascade and interact with platelets to induce thrombosis. tPA induces the degranulation of neutrophils to form NETs, leading to hemorrhagic transformation and thrombolytic resistance. NETs aggravate stroke by mediating inflammation, atherosclerosis and vascular injury. In addition, the regulation of NETs in stroke, the potential of NETs as biomarker and the treatment of stroke targeting NETs are discussed. The increasing evidences suggest that NETs may be a potential target for stroke treatment. Inhibition of NETs formation or promotion of NETs degradation plays protective effects in stroke. However, how to avoid the adverse effects of NETs-targeted therapy deserves further study. In summary, this review provides a reference for the pathogenesis, drug targets, biomarkers and drug development of NETs in stroke.
Collapse
Affiliation(s)
- Ziyuan Zhao
- Beijing Key Laboratory of Drug Targets Identification and Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100050, China
| | - Zirong Pan
- Beijing Key Laboratory of Drug Targets Identification and Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100050, China
| | - Sen Zhang
- Beijing Key Laboratory of Drug Targets Identification and Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100050, China
| | - Guodong Ma
- Beijing Key Laboratory of Drug Targets Identification and Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100050, China
| | - Wen Zhang
- Beijing Key Laboratory of Drug Targets Identification and Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100050, China
| | - Junke Song
- Beijing Key Laboratory of Drug Targets Identification and Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100050, China
| | - Yuehua Wang
- Beijing Key Laboratory of Drug Targets Identification and Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100050, China
| | - Linglei Kong
- Beijing Key Laboratory of Drug Targets Identification and Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100050, China.
| | - Guanhua Du
- Beijing Key Laboratory of Drug Targets Identification and Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100050, China.
| |
Collapse
|
5
|
Luo H, Guo H, Zhou Y, Fang R, Zhang W, Mei Z. Neutrophil Extracellular Traps in Cerebral Ischemia/Reperfusion Injury: Friend and Foe. Curr Neuropharmacol 2023; 21:2079-2096. [PMID: 36892020 PMCID: PMC10556361 DOI: 10.2174/1570159x21666230308090351] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2022] [Revised: 12/19/2022] [Accepted: 12/26/2022] [Indexed: 03/10/2023] Open
Abstract
Cerebral ischemic injury, one of the leading causes of morbidity and mortality worldwide, triggers various central nervous system (CNS) diseases, including acute ischemic stroke (AIS) and chronic ischemia-induced Alzheimer's disease (AD). Currently, targeted therapies are urgently needed to address neurological disorders caused by cerebral ischemia/reperfusion injury (CI/RI), and the emergence of neutrophil extracellular traps (NETs) may be able to relieve the pressure. Neutrophils are precursors to brain injury following ischemic stroke and exert complicated functions. NETs extracellularly release reticular complexes of neutrophils, i.e., double-stranded DNA (dsDNA), histones, and granulins. Paradoxically, NETs play a dual role, friend and foe, under different conditions, for example, physiological circumstances, infection, neurodegeneration, and ischemia/reperfusion. Increasing evidence indicates that NETs exert anti-inflammatory effects by degrading cytokines and chemokines through protease at a relatively stable and moderate level under physiological conditions, while excessive amounts of NETs release (NETosis) irritated by CI/RI exacerbate the inflammatory response and aggravate thrombosis, disrupt the blood-brain barrier (BBB), and initiates sequential neuron injury and tissue damage. This review provides a comprehensive overview of the machinery of NETs formation and the role of an abnormal cascade of NETs in CI/RI, as well as other ischemia-induced neurological diseases. Herein, we highlight the potential of NETs as a therapeutic target against ischemic stroke that may inspire translational research and innovative clinical approaches.
Collapse
Affiliation(s)
- Haoyue Luo
- Key Laboratory of Hunan Province for Integrated Traditional Chinese and Western Medicine on Prevention and Treatment of Cardio-Cerebral Diseases, College of Integrated Traditional Chinese Medicine and Western Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, 410208, China
| | - Hanjing Guo
- Key Laboratory of Hunan Province for Integrated Traditional Chinese and Western Medicine on Prevention and Treatment of Cardio-Cerebral Diseases, College of Integrated Traditional Chinese Medicine and Western Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, 410208, China
| | - Yue Zhou
- Key Laboratory of Hunan Province for Integrated Traditional Chinese and Western Medicine on Prevention and Treatment of Cardio-Cerebral Diseases, College of Integrated Traditional Chinese Medicine and Western Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, 410208, China
| | - Rui Fang
- Key Laboratory of Hunan Province for Integrated Traditional Chinese and Western Medicine on Prevention and Treatment of Cardio-Cerebral Diseases, College of Integrated Traditional Chinese Medicine and Western Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, 410208, China
| | - Wenli Zhang
- School of Pharmacy, Hunan University of Chinese Medicine, Changsha, Hunan, 410208, China
| | - Zhigang Mei
- Key Laboratory of Hunan Province for Integrated Traditional Chinese and Western Medicine on Prevention and Treatment of Cardio-Cerebral Diseases, College of Integrated Traditional Chinese Medicine and Western Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, 410208, China
- Third-Grade Pharmacological Laboratory on Chinese Medicine Approved by State Administration of Traditional Chinese Medicine, Medical College of China Three Gorges University, Yichang, Hubei, 443002, China
| |
Collapse
|
6
|
Kochetov AG, Lyang OV, Zhirova IA, Ivoylov OO, Politidis RR, Novozhenova YV. Proinflammatory laboratory predictors of pneumonia in ischemic stroke patients: prospective study. TERAPEVT ARKH 2022; 94:491-496. [DOI: 10.26442/00403660.2022.04.201460] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2022] [Accepted: 05/25/2022] [Indexed: 11/22/2022]
Abstract
Background. Bacterial pneumonia is a frequent complication of ischemic stroke at the hospital stage. The search for prognostic laboratory markers of pneumonia remains an urgent task, as it will allow to individualize the approach to the treatment and rehabilitation of such patients.
Aim. To investigate the prognostic significance of proteins of the acute phase of inflammation, as well as to evaluate them as early predictors of the development of pneumonia in patients with ischemic stroke.
Materials and methods. The study included 302 patients in the acute period of ischemic stroke. C-reactive protein (CRP), tumor necrosis factor , interleukin-6 (IL-6), neutrophil elastase, neopterin, serum amyloid A (SAA), secreted phospholipase type 2 (sPLA2) were determined in all patients on the first day by enzyme immunoassay. Statistical data processing was carried out using SPSS and Microsoft Excel software (USA).
Results. At the hospital stage, pneumonia developed in 82/302 patients (27.2%; 95% confidence interval 22.332.3%). The levels of CRP, IL-6, sPLA2, SAA and neopterin significantly differed in the presence and absence of pneumonia. Step-by-step logistic regression analysis revealed the significance of IL-6 and CRP concentrations in the prognosis of pneumonia. The threshold value of IL-6 concentration was 3.45 pg/ml (sensitivity 82.4%, specificity 66.7%). The prognostic value of a positive result (PPR) in the prognosis of pneumonia was 40%, a negative result (PNR) 92%. The threshold value of CRP was 1640 mg/l with a sensitivity of 65.8% and a specificity of 74.8%. The PPR of the threshold value of the concentration of CRP was 45%, PNR 80%.
Conclusion. The measurement of the concentration of IL-6 and CRP on the first day of ischemic stroke makes it possible to identify patients with the greatest risk of pneumonia at the hospital stage. The results of the work indicate the necessity to include CRP and IL-6 in the list of mandatory laboratory tests that should be carried out for each patient with ischemic stroke on the first day from the onset of the disease.
Collapse
|
7
|
Lobo Chaves MA, Gittins M, Bray B, Vail A, Smith CJ. The Timing of Stroke Care Processes and Development of Stroke Associated Pneumonia: A National Registry Cohort Study. Front Neurol 2022; 13:875893. [PMID: 35493828 PMCID: PMC9043446 DOI: 10.3389/fneur.2022.875893] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2022] [Accepted: 03/23/2022] [Indexed: 12/04/2022] Open
Abstract
Introduction Timely stroke care can result in significant improvements in stroke recovery. However, little is known about how stroke care processes relate to complications such as the development of stroke associated pneumonia (SAP). Here we investigated associations between stroke care processes, their timing and development of SAP. Methods We obtained patient-level data from the Sentinel Stroke National Audit Programme for all confirmed strokes between 1st April 2013 and 31st December 2018. SAP was identified if new antibiotic initiation for pneumonia occurred within the first 7 days of admission. Time to key stroke care processes in the pre-hospital, hyperacute and acute phase were investigated. A mixed effects logistic regression model estimated the association between SAP [Odds ratios (OR) with 95% CI] and each process of care after controlling for pre-determined confounders such as age, stroke severity and comorbidities. Results SAP was identified in 8.5% of 413,133 patients in 169 stroke units. A long time to arrival at a stroke unit after symptom onset or time last seen well [OR (95% CI) = 1.29 (1.23-1.35)], from admission to assessment by a stroke specialist [1.10 (1.06-1.14)] and from admission to assessment by a physiotherapist [1.16 (1.12-1.21)] were all independently associated with SAP. Short door to needle times were associated with lower odds of SAP [0.90 (0.83-0.97)]. Conclusion Times from stroke onset and admission to certain key stroke care processes were associated with SAP. Understanding how timing of these care processes relate to SAP may enable development of preventive interventions to reduce antibiotic use and improve clinical outcomes.
Collapse
Affiliation(s)
- Marco Antonio Lobo Chaves
- Division of Cardiovascular Sciences, School of Medical Sciences, University of Manchester, Manchester, United Kingdom
- Geoffrey Jefferson Brain Research Centre, Manchester, United Kingdom
| | - Matthew Gittins
- Geoffrey Jefferson Brain Research Centre, Manchester, United Kingdom
- Centre for Biostatistics, University of Manchester, Manchester, United Kingdom
| | - Benjamin Bray
- School of Population Health and Environmental Sciences, King's College London, London, United Kingdom
| | - Andy Vail
- Geoffrey Jefferson Brain Research Centre, Manchester, United Kingdom
- Centre for Biostatistics, University of Manchester, Manchester, United Kingdom
| | - Craig J. Smith
- Division of Cardiovascular Sciences, School of Medical Sciences, University of Manchester, Manchester, United Kingdom
- Geoffrey Jefferson Brain Research Centre, Manchester, United Kingdom
- Manchester Centre for Clinical Neurosciences, Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Salford Royal National Health Service (NHS) Foundation Trust, Salford, United Kingdom
| |
Collapse
|
8
|
Wang L, Pan J, Sun Y, Zong S, Zhang R, Li Y, Yu Z, Liu J, Zang S. Increased Neutrophil elastase and proteinase 3 are closely associated with occurrence and severity of stroke and acute myocardial infarction in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 2022; 186:109853. [PMID: 35341779 DOI: 10.1016/j.diabres.2022.109853] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/10/2021] [Revised: 03/07/2022] [Accepted: 03/22/2022] [Indexed: 11/03/2022]
Abstract
AIMS The role of Neutrophil elastase (NE) and proteinase 3 (PR3) in the occurrence and severity of stroke and acute myocardial infarction (AMI) have not been explored in type 2 diabetes mellitus (T2DM). This study aimed to investigate the relationship and predictive ability of NE and PR3 in the development of stroke and AMI in patients with T2DM, and to explore the pattern of NE and PR3 in atherosclerotic plaques. METHODS 465 patients with T2DM (stroke or AMI, n = 234; non stroke or AMI, n = 231) were recruited. Clinical characteristics, and NE and PR3 concentration were measured in all subjects. Semi-quantitative analysis of immunohistochemistry staining for NE and PR3 was performed in detached emboli and stable plaques. RESULTS Patients with stroke or AMI had a higher level of NE and PR3, with a more pronounced increase in more severe cases (higher mRS score in stroke and Gensini score in AMI) and associated with clinical markers. An increase in NE and PR3 was an independent risk factor for stroke (OR = 4.318, P = 0.017; OR = 2.979, P = 0.048, respectively) and AMI (OR = 8.385, P = 0.015; OR = 5.540, P = 0.047). Finally, immunohistochemistry staining revealed that the NE and PR3 positive area increased significantly in detached emboli compared with stable plaques. CONCLUSION Increased NE and PR3 was associated with occurrence and severity of stroke and AMI in patients with T2DM. Enriched NE and PR3 in detached emboli may be associated with plaque vulnerability.
Collapse
Affiliation(s)
- Lihong Wang
- Department of Endocrinology, Shanghai Fifth People's Hospital, Fudan University, 801 Heqin Road, Shanghai 200240, China
| | - Jie Pan
- Department of General Surgery, Shanghai Fifth People's Hospital, Fudan University, 801 Heqin Road, Shanghai 200240, China
| | - Yifan Sun
- Department of Endocrinology, Shanghai Fifth People's Hospital, Fudan University, 801 Heqin Road, Shanghai 200240, China
| | - Shuhang Zong
- Department of Endocrinology, Shanghai Fifth People's Hospital, Fudan University, 801 Heqin Road, Shanghai 200240, China
| | - Rui Zhang
- Department of Endocrinology, Shanghai Fifth People's Hospital, Fudan University, 801 Heqin Road, Shanghai 200240, China
| | - Yue Li
- Department of Endocrinology, Shanghai Fifth People's Hospital, Fudan University, 801 Heqin Road, Shanghai 200240, China
| | - Zhiyan Yu
- Department of Endocrinology, Shanghai Fifth People's Hospital, Fudan University, 801 Heqin Road, Shanghai 200240, China
| | - Jun Liu
- Department of Endocrinology, Shanghai Fifth People's Hospital, Fudan University, 801 Heqin Road, Shanghai 200240, China
| | - Shufei Zang
- Department of Endocrinology, Shanghai Fifth People's Hospital, Fudan University, 801 Heqin Road, Shanghai 200240, China.
| |
Collapse
|
9
|
Neutrophil Extracellular Traps Exacerbate Ischemic Brain Damage. Mol Neurobiol 2021; 59:643-656. [PMID: 34748205 DOI: 10.1007/s12035-021-02635-z] [Citation(s) in RCA: 38] [Impact Index Per Article: 12.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2021] [Accepted: 11/02/2021] [Indexed: 12/11/2022]
Abstract
Most acute strokes are ischemic, and subsequent neuroinflammation promotes further damage leading to cell death but also plays a beneficial role by promoting cellular repair. Neutrophils are forerunners to brain lesions after ischemic stroke and exert elaborate functions. While neutrophil extracellular traps (NETs) possess a fundamental antimicrobial function within the innate immune system under physiological circumstances, increasing evidence indicates that NETosis, the release process of NETs, occurs in the pathogenic process of stroke. In this review, we focus on the processes of NET formation and clearance, the temporal and spatial alterations of neutrophils and NETs after ischemic damage, and how NETs are involved in several stroke-related phenomena. Generally, NET formation and release processes depend on the generation of reactive oxygen species (ROS) and the activation of nuclear peptidylarginine deiminase-4 (PAD4). The acid-base environment, oxygen concentration, and iron ions around the infarct may also impact NET formation. DNase 1 has been identified as the primary degrader of NETs in serum, while reactive microglia are expected to inhibit the formation of NETs around ischemic lesions by phagocytosis of neutrophils. The neutrophils and NETs are present in the perivascular space ipsilateral to the infarct arising after ischemic damage, peaking between 1 and 3 days postischemia, but their location in the brain parenchyma remains controversial. After the ischemic injury, NETs are involved in the destruction of neurological function primarily by disrupting the blood-brain barrier and promoting thrombosis. The potential effects of NETs on various ischemic nerve cells need to be further investigated, especially in the chronic ischemic phase.
Collapse
|
10
|
Huang Y, Li F, Chen Z, Chen W, Fan L, Zheng Y, Han Z, Li L, Luo Y, Zhang Y. Predictive Value of Degranulating Factors of Neutrophils in Massive Cerebral Infarction. Cell Transplant 2021; 30:9636897211004089. [PMID: 33787356 PMCID: PMC8020096 DOI: 10.1177/09636897211004089] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023] Open
Abstract
Massive cerebral infarction (MCI) is a life-threatening disease and may lead to
cerebral herniation. Neutrophil degranulation contributes to ischemic injury in
the early stage. To investigate whether neutrophil degranulating factors can
predict cerebral herniation and the long-term prognosis of patients with MCI and
to investigate the relationship between neutrophil degranulation and blood brain
barrier (BBB) damage. In this case-control study of 14 MCI patients, we divided
the patients into a cerebral hernia group and no cerebral hernia group according
to whether they developed cerebral herniation within 5 days. The prognosis of
MCI patients was assessed using the Modified Rankin Scale (mRS) score at 6
months, which was the primary end point. The composition of white blood cells
(WBC) and degranulating factors for neutrophils in the plasma of MCI patients
was determined on days 2 and 4. Baseline characteristics were comparable in both
groups. The neurological functional scores and long-term prognosis showed no
difference between patients with or without cerebral herniation, while the
mortality rate of the cerebral hernia group in the short term was higher
(P < 0.05). The WBC count, neutrophil to lymphocyte
ratio (NLR) and plasma myeloperoxidase (MPO) levels of patients with cerebral
hernia were significantly higher than those of patients without cerebral hernia
(all P < 0.05). MPO is a better predictor of cerebral
herniation, and the NLR showed superior predictive value in the prognosis of MCI
patients. neutrophil degranulation may play an important role in malignant
cerebral hernia during MCI. These data suggest that, MPO and the NLR might be
predictive factors for cerebral herniation and the prognosis of MCI
patients.
Collapse
Affiliation(s)
- Yuyou Huang
- Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China.,Institute of Cerebrovascular Diseases Research, Xuanwu Hospital of Capital Medical University, Beijing, China
| | - Fangfang Li
- Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China.,Institute of Cerebrovascular Diseases Research, Xuanwu Hospital of Capital Medical University, Beijing, China
| | - Zhongyun Chen
- Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China
| | - Weibi Chen
- Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China
| | - Linlin Fan
- Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China
| | - Yangmin Zheng
- Institute of Cerebrovascular Diseases Research, Xuanwu Hospital of Capital Medical University, Beijing, China
| | - Ziping Han
- Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China.,Institute of Cerebrovascular Diseases Research, Xuanwu Hospital of Capital Medical University, Beijing, China.,Beijing Geriatric Medical Research Center and Beijing Key Laboratory of Translational Medicine for Cerebrovascular Diseases, Beijing, China
| | - Lingzhi Li
- Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China.,Institute of Cerebrovascular Diseases Research, Xuanwu Hospital of Capital Medical University, Beijing, China
| | - Yumin Luo
- Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China.,Institute of Cerebrovascular Diseases Research, Xuanwu Hospital of Capital Medical University, Beijing, China.,Beijing Geriatric Medical Research Center and Beijing Key Laboratory of Translational Medicine for Cerebrovascular Diseases, Beijing, China.,Beijing Institute for Brain Disorders, 12517Capital Medical University, Beijing, China
| | - Yan Zhang
- Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China.,Beijing Institute for Brain Disorders, 12517Capital Medical University, Beijing, China
| |
Collapse
|
11
|
Xie P, Ren ZK, Lv J, Hu YM, Guan ZZ, Yu WF. Berberine Ameliorates Oxygen-glucose Deprivation/Reperfusion-induced Apoptosis by Inhibiting Endoplasmic Reticulum Stress and Autophagy in PC12 Cells. Curr Med Sci 2021; 40:1047-1056. [PMID: 33428132 DOI: 10.1007/s11596-020-2286-x] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2020] [Accepted: 11/30/2020] [Indexed: 02/06/2023]
Abstract
This study aimed to elucidate the molecular mechanisms by which berberine protects against cerebral ischemia/reperfusion (I/R) injury. The oxygen-glucose deprivation/reperfusion (OGD/R) PC12 model was established. Cell counting kit-8 (CCK-8) was used to detect the toxicity of berberine and the viability of PC12 cells. Hoechst 33258 staining and flow cytometry were used to observe the nuclear morphology, and changes of apoptosis and reactive oxygen species (ROS), respectively. Western blotting and immunofluorescence assay were employed to detect autophagy-related proteins [microtubule-associated protein 1A/1B-light chain 3 (LC3), P62/SQSTM-1, Beclin-1] and endoplasmic reticulum (ER) stress-related markers [glucose-regulated protein 78 (GRP78), C/EBP homologous protein (CHOP), Bcl-2-associated X (Bax) and cleaved caspase-3]. The GFP-RFP-LC3 adenovirus was used to assay the change of autophagic flux. Our results showed that berberine could increase the viability of PC12 cells, decrease the concentrations of ROS after OGD/R treatment, and suppress OGD/R-induced ER stress and autophagy. Moreover, the results revealed the involvement of the mammalian target of rapamycin (mTOR) pathway in the induction of autophagy, and berberine could activate the phosphorylation of mTOR and thus mitigate autophagy. In conclusion, our study suggested that berberine may protect against OGD/R-induced apoptosis by regulating ER stress and autophagy, and it holds promises in the treatment of cerebral I/R injury.
Collapse
Affiliation(s)
- Peng Xie
- Department of Biochemistry and Molecular Biology, School of Basic Medical Science, Guizhou Medical University, Guiyang, 550025, China.,Key Laboratory of Endemic and Ethnic Diseases, Ministry of Education, Guiyang, 550004, China
| | - Zhen-Kui Ren
- Department of Biochemistry and Molecular Biology, School of Basic Medical Science, Guizhou Medical University, Guiyang, 550025, China.,Key Laboratory of Endemic and Ethnic Diseases, Ministry of Education, Guiyang, 550004, China.,Department of Laboratory Medicine, the Second People's Hospital of Guizhou Province, Guiyang, 550002, China
| | - Ju Lv
- Department of Biochemistry and Molecular Biology, School of Basic Medical Science, Guizhou Medical University, Guiyang, 550025, China.,Key Laboratory of Endemic and Ethnic Diseases, Ministry of Education, Guiyang, 550004, China
| | - Yu-Mei Hu
- Department of Biochemistry and Molecular Biology, School of Basic Medical Science, Guizhou Medical University, Guiyang, 550025, China.,Key Laboratory of Endemic and Ethnic Diseases, Ministry of Education, Guiyang, 550004, China
| | - Zhi-Zhong Guan
- Key Laboratory of Endemic and Ethnic Diseases, Ministry of Education, Guiyang, 550004, China.,Department of Pathology, Affiliated Hospital of Guizhou Medical University, Guiyang, 550004, China
| | - Wen-Feng Yu
- Department of Biochemistry and Molecular Biology, School of Basic Medical Science, Guizhou Medical University, Guiyang, 550025, China. .,Key Laboratory of Endemic and Ethnic Diseases, Ministry of Education, Guiyang, 550004, China.
| |
Collapse
|
12
|
van Gemmeren T, Schuppner R, Grosse GM, Fering J, Gabriel MM, Huber R, Worthmann H, Lichtinghagen R, Weissenborn K. Early Post-Stroke Infections Are Associated with an Impaired Function of Neutrophil Granulocytes. J Clin Med 2020; 9:jcm9030872. [PMID: 32209993 PMCID: PMC7141520 DOI: 10.3390/jcm9030872] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2020] [Revised: 03/11/2020] [Accepted: 03/18/2020] [Indexed: 01/02/2023] Open
Abstract
To investigate whether neutrophil granulocytes’ function relates to post-stroke infections and clinical outcome after stroke, we prospectively recruited 95 patients after ischemic stroke and tested them for their microbiocidal neutrophil functions in this exploratory study. Additionally, 24 age-adjusted controls were examined regarding neutrophil function. Phagocytic capacity and the ability of the neutrophil granulocytes to produce reactive oxygen species (ROS) as well as CD11b and CD16 receptor expression profile were measured by flow cytometry at days 1, 3, 7, and 90 after symptom onset. Primary outcome was the development of an infection within the first week after stroke. Results of neutrophil functional measurements were compared between patients with and without infection as well as between all stroke patients and controls. Further risk factors for the development of infections were summarized in an infection-risk score for the purpose of multivariate statistical analysis. The ROS production in neutrophils after stimulation with formyl-methionyl-leucyl-phenylalanine (fMLP) was reduced at baseline in patients with post-stroke infections compared to those without (p = 0.013). This difference proved to be independent from the infection-risk score in the binary logistic regression (p = 0.011). Phagocytosis and oxidative bursts were not significantly reduced in the whole stroke patient group compared to controls. Dysfunction of neutrophil granulocytes seems to play a significant role in the development of post-stroke infections. Further studies are warranted to investigate neutrophil granulocytes´ function as a potential biomarker of post-stroke infections.
Collapse
Affiliation(s)
- Till van Gemmeren
- Department of Neurology, Hannover Medical School, 30625 Hannover, Germany; (T.v.G.); (G.M.G.); (J.F.); (M.M.G.); (H.W.); (K.W.)
| | - Ramona Schuppner
- Department of Neurology, Hannover Medical School, 30625 Hannover, Germany; (T.v.G.); (G.M.G.); (J.F.); (M.M.G.); (H.W.); (K.W.)
- Correspondence: ; Tel.: +49-511-532-3580; Fax: +49-511-532-18625
| | - Gerrit M. Grosse
- Department of Neurology, Hannover Medical School, 30625 Hannover, Germany; (T.v.G.); (G.M.G.); (J.F.); (M.M.G.); (H.W.); (K.W.)
| | - Jessica Fering
- Department of Neurology, Hannover Medical School, 30625 Hannover, Germany; (T.v.G.); (G.M.G.); (J.F.); (M.M.G.); (H.W.); (K.W.)
| | - Maria M. Gabriel
- Department of Neurology, Hannover Medical School, 30625 Hannover, Germany; (T.v.G.); (G.M.G.); (J.F.); (M.M.G.); (H.W.); (K.W.)
| | - René Huber
- Institute of Clinical Chemistry, Hannover Medical School, 30625 Hannover, Germany; (R.H.); (R.L.)
| | - Hans Worthmann
- Department of Neurology, Hannover Medical School, 30625 Hannover, Germany; (T.v.G.); (G.M.G.); (J.F.); (M.M.G.); (H.W.); (K.W.)
| | - Ralf Lichtinghagen
- Institute of Clinical Chemistry, Hannover Medical School, 30625 Hannover, Germany; (R.H.); (R.L.)
| | - Karin Weissenborn
- Department of Neurology, Hannover Medical School, 30625 Hannover, Germany; (T.v.G.); (G.M.G.); (J.F.); (M.M.G.); (H.W.); (K.W.)
| |
Collapse
|
13
|
Weisenburger-Lile D, Dong Y, Yger M, Weisenburger G, Polara GF, Chaigneau T, Ochoa RZ, Marro B, Lapergue B, Alamowitch S, Elbim C. Harmful neutrophil subsets in patients with ischemic stroke: Association with disease severity. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION 2019; 6:e571. [PMID: 31355307 PMCID: PMC6624098 DOI: 10.1212/nxi.0000000000000571] [Citation(s) in RCA: 55] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/19/2018] [Accepted: 03/12/2019] [Indexed: 12/22/2022]
Abstract
Objective To better understand the functional state of circulating neutrophils in patients with ischemic stroke (IS) for planning future clinical trials. Methods We analyzed by flow cytometry activation state of circulating neutrophils and the distribution of neutrophil peripheral subsets in 41 patients with acute IS less than 6 hours before admission and compared them with 22 age-matched healthy controls. Results Our results demonstrated continuous basal hyperactivation of circulating neutrophils during acute IS, characterized by lower l-selectin expression and higher CD11b expression at the cell surface, increased ROS production by neutrophils, and greater circulating levels of neutrophil elastase. Neutrophil hyperactivation was associated with deregulation of the equilibrium between apoptotic and necrotic. Patients also had higher percentages than controls of the overactive senescent (CXCR4bright/CD62Ldim) neutrophil subset and increased percentage of neutrophils with a reverse transendothelial migration (CD54highCXCR1low) phenotype. Importantly, neutrophil alterations were associated with the clinical severity of the stroke, evaluated by its NIH Stroke Scale score. Conclusion Altogether, our results indicate that during acute IS, the inflammatory properties of circulating neutrophils rise, associated with the expansion of harmful neutrophil subsets. These changes in neutrophil homeostasis, associated with disease severity, may play an instrumental role by contributing to systemic inflammation and to the blood-brain barrier breakdown. Our findings highlight new potential therapeutic approaches of stroke by rebalancing the ratio of senescent to immunosuppressive neutrophils or decreasing reverse neutrophil transmigration or both.
Collapse
Affiliation(s)
- David Weisenburger-Lile
- Sorbonne Universités (D.W.-L., Y.D., T.C., R.Z.O., S.A., C.E.), UPMC Univ Paris 06, UMRS 938, CdR Saint-Antoine, Hôpital Saint-Antoine; INSERM (D.W.-L., Y.D., T.C., R.Z.O., S.A., C.E.), UMRS 938, CdR Saint- Antoine, Team "Immune System, Neuroinflammation and Neurodegenerative Diseases," Hôpital St-Antoine; Service de Neurologie et d'Urgences Neurovasculaires (D.W.-L., M.Y., S.A.), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine; Division of Pneumology (G.W.), Foch Hospital, F-92150, Suresnes; Division of Neurology (G.F.P.), Stroke Center, Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière Hospital; Division of Radiology (B.M.), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine; and Division of Neurology (B.L.), Stroke Center, Foch Hospital, F-92150, Suresnes
| | - Yuan Dong
- Sorbonne Universités (D.W.-L., Y.D., T.C., R.Z.O., S.A., C.E.), UPMC Univ Paris 06, UMRS 938, CdR Saint-Antoine, Hôpital Saint-Antoine; INSERM (D.W.-L., Y.D., T.C., R.Z.O., S.A., C.E.), UMRS 938, CdR Saint- Antoine, Team "Immune System, Neuroinflammation and Neurodegenerative Diseases," Hôpital St-Antoine; Service de Neurologie et d'Urgences Neurovasculaires (D.W.-L., M.Y., S.A.), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine; Division of Pneumology (G.W.), Foch Hospital, F-92150, Suresnes; Division of Neurology (G.F.P.), Stroke Center, Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière Hospital; Division of Radiology (B.M.), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine; and Division of Neurology (B.L.), Stroke Center, Foch Hospital, F-92150, Suresnes
| | - Marion Yger
- Sorbonne Universités (D.W.-L., Y.D., T.C., R.Z.O., S.A., C.E.), UPMC Univ Paris 06, UMRS 938, CdR Saint-Antoine, Hôpital Saint-Antoine; INSERM (D.W.-L., Y.D., T.C., R.Z.O., S.A., C.E.), UMRS 938, CdR Saint- Antoine, Team "Immune System, Neuroinflammation and Neurodegenerative Diseases," Hôpital St-Antoine; Service de Neurologie et d'Urgences Neurovasculaires (D.W.-L., M.Y., S.A.), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine; Division of Pneumology (G.W.), Foch Hospital, F-92150, Suresnes; Division of Neurology (G.F.P.), Stroke Center, Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière Hospital; Division of Radiology (B.M.), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine; and Division of Neurology (B.L.), Stroke Center, Foch Hospital, F-92150, Suresnes
| | - Gaëlle Weisenburger
- Sorbonne Universités (D.W.-L., Y.D., T.C., R.Z.O., S.A., C.E.), UPMC Univ Paris 06, UMRS 938, CdR Saint-Antoine, Hôpital Saint-Antoine; INSERM (D.W.-L., Y.D., T.C., R.Z.O., S.A., C.E.), UMRS 938, CdR Saint- Antoine, Team "Immune System, Neuroinflammation and Neurodegenerative Diseases," Hôpital St-Antoine; Service de Neurologie et d'Urgences Neurovasculaires (D.W.-L., M.Y., S.A.), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine; Division of Pneumology (G.W.), Foch Hospital, F-92150, Suresnes; Division of Neurology (G.F.P.), Stroke Center, Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière Hospital; Division of Radiology (B.M.), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine; and Division of Neurology (B.L.), Stroke Center, Foch Hospital, F-92150, Suresnes
| | - Giulia Frasca Polara
- Sorbonne Universités (D.W.-L., Y.D., T.C., R.Z.O., S.A., C.E.), UPMC Univ Paris 06, UMRS 938, CdR Saint-Antoine, Hôpital Saint-Antoine; INSERM (D.W.-L., Y.D., T.C., R.Z.O., S.A., C.E.), UMRS 938, CdR Saint- Antoine, Team "Immune System, Neuroinflammation and Neurodegenerative Diseases," Hôpital St-Antoine; Service de Neurologie et d'Urgences Neurovasculaires (D.W.-L., M.Y., S.A.), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine; Division of Pneumology (G.W.), Foch Hospital, F-92150, Suresnes; Division of Neurology (G.F.P.), Stroke Center, Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière Hospital; Division of Radiology (B.M.), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine; and Division of Neurology (B.L.), Stroke Center, Foch Hospital, F-92150, Suresnes
| | - Thomas Chaigneau
- Sorbonne Universités (D.W.-L., Y.D., T.C., R.Z.O., S.A., C.E.), UPMC Univ Paris 06, UMRS 938, CdR Saint-Antoine, Hôpital Saint-Antoine; INSERM (D.W.-L., Y.D., T.C., R.Z.O., S.A., C.E.), UMRS 938, CdR Saint- Antoine, Team "Immune System, Neuroinflammation and Neurodegenerative Diseases," Hôpital St-Antoine; Service de Neurologie et d'Urgences Neurovasculaires (D.W.-L., M.Y., S.A.), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine; Division of Pneumology (G.W.), Foch Hospital, F-92150, Suresnes; Division of Neurology (G.F.P.), Stroke Center, Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière Hospital; Division of Radiology (B.M.), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine; and Division of Neurology (B.L.), Stroke Center, Foch Hospital, F-92150, Suresnes
| | - Riccardo Zapata Ochoa
- Sorbonne Universités (D.W.-L., Y.D., T.C., R.Z.O., S.A., C.E.), UPMC Univ Paris 06, UMRS 938, CdR Saint-Antoine, Hôpital Saint-Antoine; INSERM (D.W.-L., Y.D., T.C., R.Z.O., S.A., C.E.), UMRS 938, CdR Saint- Antoine, Team "Immune System, Neuroinflammation and Neurodegenerative Diseases," Hôpital St-Antoine; Service de Neurologie et d'Urgences Neurovasculaires (D.W.-L., M.Y., S.A.), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine; Division of Pneumology (G.W.), Foch Hospital, F-92150, Suresnes; Division of Neurology (G.F.P.), Stroke Center, Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière Hospital; Division of Radiology (B.M.), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine; and Division of Neurology (B.L.), Stroke Center, Foch Hospital, F-92150, Suresnes
| | - Beatrice Marro
- Sorbonne Universités (D.W.-L., Y.D., T.C., R.Z.O., S.A., C.E.), UPMC Univ Paris 06, UMRS 938, CdR Saint-Antoine, Hôpital Saint-Antoine; INSERM (D.W.-L., Y.D., T.C., R.Z.O., S.A., C.E.), UMRS 938, CdR Saint- Antoine, Team "Immune System, Neuroinflammation and Neurodegenerative Diseases," Hôpital St-Antoine; Service de Neurologie et d'Urgences Neurovasculaires (D.W.-L., M.Y., S.A.), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine; Division of Pneumology (G.W.), Foch Hospital, F-92150, Suresnes; Division of Neurology (G.F.P.), Stroke Center, Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière Hospital; Division of Radiology (B.M.), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine; and Division of Neurology (B.L.), Stroke Center, Foch Hospital, F-92150, Suresnes
| | - Bertrand Lapergue
- Sorbonne Universités (D.W.-L., Y.D., T.C., R.Z.O., S.A., C.E.), UPMC Univ Paris 06, UMRS 938, CdR Saint-Antoine, Hôpital Saint-Antoine; INSERM (D.W.-L., Y.D., T.C., R.Z.O., S.A., C.E.), UMRS 938, CdR Saint- Antoine, Team "Immune System, Neuroinflammation and Neurodegenerative Diseases," Hôpital St-Antoine; Service de Neurologie et d'Urgences Neurovasculaires (D.W.-L., M.Y., S.A.), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine; Division of Pneumology (G.W.), Foch Hospital, F-92150, Suresnes; Division of Neurology (G.F.P.), Stroke Center, Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière Hospital; Division of Radiology (B.M.), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine; and Division of Neurology (B.L.), Stroke Center, Foch Hospital, F-92150, Suresnes
| | - Sonia Alamowitch
- Sorbonne Universités (D.W.-L., Y.D., T.C., R.Z.O., S.A., C.E.), UPMC Univ Paris 06, UMRS 938, CdR Saint-Antoine, Hôpital Saint-Antoine; INSERM (D.W.-L., Y.D., T.C., R.Z.O., S.A., C.E.), UMRS 938, CdR Saint- Antoine, Team "Immune System, Neuroinflammation and Neurodegenerative Diseases," Hôpital St-Antoine; Service de Neurologie et d'Urgences Neurovasculaires (D.W.-L., M.Y., S.A.), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine; Division of Pneumology (G.W.), Foch Hospital, F-92150, Suresnes; Division of Neurology (G.F.P.), Stroke Center, Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière Hospital; Division of Radiology (B.M.), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine; and Division of Neurology (B.L.), Stroke Center, Foch Hospital, F-92150, Suresnes
| | - Carole Elbim
- Sorbonne Universités (D.W.-L., Y.D., T.C., R.Z.O., S.A., C.E.), UPMC Univ Paris 06, UMRS 938, CdR Saint-Antoine, Hôpital Saint-Antoine; INSERM (D.W.-L., Y.D., T.C., R.Z.O., S.A., C.E.), UMRS 938, CdR Saint- Antoine, Team "Immune System, Neuroinflammation and Neurodegenerative Diseases," Hôpital St-Antoine; Service de Neurologie et d'Urgences Neurovasculaires (D.W.-L., M.Y., S.A.), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine; Division of Pneumology (G.W.), Foch Hospital, F-92150, Suresnes; Division of Neurology (G.F.P.), Stroke Center, Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière Hospital; Division of Radiology (B.M.), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine; and Division of Neurology (B.L.), Stroke Center, Foch Hospital, F-92150, Suresnes
| |
Collapse
|
14
|
Ouk T, Potey C, Maestrini I, Petrault M, Mendyk AM, Leys D, Bordet R, Gautier S. Neutrophils in tPA-induced hemorrhagic transformations: Main culprit, accomplice or innocent bystander? Pharmacol Ther 2019; 194:73-83. [DOI: 10.1016/j.pharmthera.2018.09.005] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
|
15
|
McCulloch L, Alfieri A, McColl BW. Experimental Stroke Differentially Affects Discrete Subpopulations of Splenic Macrophages. Front Immunol 2018; 9:1108. [PMID: 29872438 PMCID: PMC5972287 DOI: 10.3389/fimmu.2018.01108] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2018] [Accepted: 05/02/2018] [Indexed: 12/24/2022] Open
Abstract
Changes to the immune system after stroke are complex and can result in both pro-inflammatory and immunosuppressive consequences. Following ischemic stroke, brain resident microglia are activated and circulating monocytes are recruited to the injury site. In contrast, there is a systemic deactivation of monocytes/macrophages that may contribute to immunosuppression and the high incidence of bacterial infection experienced by stroke patients. The manipulation of macrophage subsets may be a useful therapeutic strategy to reduce infection and improve outcome in patients after stroke. Recent research has enhanced our understanding of the heterogeneity of macrophages even within the same tissue. The spleen is the largest natural reservoir of immune cells, many of which are mobilized to the site of injury after ischemic stroke and is notable for the diversity of its functionally distinct macrophage subpopulations associated with specific micro-anatomical locations. Here, we describe the effects of experimental stroke in mice on these distinct splenic macrophage subpopulations. Red pulp (RP) and marginal zone macrophages (MZM) specifically showed increases in density and alterations in micro-anatomical location. These changes were not due to increased recruitment from the bone marrow but may be associated with increases in local proliferation. Genes associated with phagocytosis and proteolytic processing were upregulated in the spleen after stroke with increased expression of the lysosome-associated protein lysosomal-associated membrane proteins specifically increased in RP and MZM subsets. In contrast, MHC class II expression was reduced specifically in these populations. Furthermore, genes associated with macrophage ability to communicate with other immune cells, such as co-stimulatory molecules and inflammatory cytokine production, were also downregulated in the spleen after stroke. These findings suggest that selective splenic macrophage functions could be impaired after stroke and the contribution of macrophages to stroke-associated pathology and infectious complications should be considered at a subset-specific level. Therefore, optimal therapeutic manipulation of macrophages to improve stroke outcome is likely to require selective targeting of functionally and spatially distinct subpopulations.
Collapse
Affiliation(s)
- Laura McCulloch
- UK Dementia Research Institute, Edinburgh Medcial School, University of Edinburgh, Edinburgh, United Kingdom.,Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom
| | - Alessio Alfieri
- Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom
| | - Barry W McColl
- UK Dementia Research Institute, Edinburgh Medcial School, University of Edinburgh, Edinburgh, United Kingdom.,Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom
| |
Collapse
|